Polyplus acquires Xpress Biologics to expand plasmid DNA
The acquisition will strategically expand the Polyplus plasmid DNA engineering technology and services portfolio
Polyplus | 08/12/2022 | By Sudeep Soparkar | 359
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy